OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

BIAS: Center
RELIABILITY: Mixed
CNBC
12:30Z

OpenEvidence, based in Massachusetts, has topped a $12 billion valuation in a funding round led by Thrive and DST.

Continue reading at the original source

Read Full Article at CNBC →